Audit 41573

FY End
2022-06-30
Total Expended
$99.91M
Findings
4
Programs
30
Organization: Mercy Health (MO)
Year: 2022 Accepted: 2023-03-30

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
45981 2022-001 Material Weakness Yes AE
45982 2022-002 Significant Deficiency - L
622423 2022-001 Material Weakness Yes AE
622424 2022-002 Significant Deficiency - L

Programs

ALN Program Spent Major Findings
93.498 Covid-19: Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $81.69M Yes 1
93.461 Covid 19: Hrsa Covid-19 Claims Reimbursement for the Uninsured Program and the Covid-19 Coverage Assistance Fund $14.28M Yes 1
93.103 Food and Drug Administration Research $409,941 - 0
16.575 Crime Victim Assistance $375,488 - 0
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $275,154 - 0
21.019 Covid-19: Coronavirus Relief Fund $255,481 - 0
32.006 Covid-19: Covid-19 Telehealth Program $139,717 - 0
93.426 Improving the Health of Americans Through Prevention and Management of Diabetes and Heart Disease and Stroke $106,815 - 0
93.558 Temporary Assistance for Needy Families $99,779 - 0
93.671 Family Violence Prevention and Services/domestic Violence Shelter and Supportive Services $72,531 - 0
93.889 Covid-19: National Bioterrorism Hospital Preparedness Program $62,205 - 0
16.588 Violence Against Women Formula Grants $45,823 - 0
93.898 Cancer Prevention and Control Programs for State, Territorial and Tribal Organizations $34,679 - 0
14.231 Emergency Solutions Grant Program $31,795 - 0
93.558 Covid-19: Temporary Assistance for Needy Families $30,272 - 0
93.945 Assistance Program for Chronic Disease Prevention and Control $29,666 - 0
93.350 National Center for Advancing Translational Sciences $20,172 - 0
93.310 Trans-Nih Research Support $15,436 - 0
10.558 Child and Adult Care Food Program $13,240 - 0
16.590 Grants to Encourage Arrest Policies and Enforcement of Protection Orders Program $11,402 - 0
93.301 Small Rural Hospital Improvement Grant Program $11,359 - 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $8,415 - 0
93.994 Maternal and Child Health Services Block Grant to the States $6,320 - 0
14.231 Covid-19: Emergency Solutions Grant Program $5,589 - 0
20.600 State and Community Highway Safety $5,165 - 0
93.889 National Bioterrorism Hospital Preparedness Program $4,000 - 0
21.027 Covid-19: Coronavirus State and Local Fiscal Recovery Funds $3,489 - 0
93.667 Social Services Block Grant $2,227 - 0
10.855 Distance Learning and Telemedicine Loans and Grants $1,348 - 0
93.671 Covid-19: Family Violence Prevention and Services/domestic Violence Shelter and Supportive Services $496 - 0

Contacts

Name Title Type
GB9NVW4QNBA6 Jill McCart Auditee
3143643891 Randy Koning Auditor
No contacts on file

Notes to SEFA

Title: 3. Donated Pharmaceuticals (Unaudited) Accounting Policies: The accompanying schedule of expenditures of federal awards (Schedule) includes the federal grant activity of Mercy Health and is presented on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. Mercy Healths reporting entity is defined in Mercy Healths consolidated financial statements. De Minimis Rate Used: Both Rate Explanation: Indirect cost rates for certain Mercy Health entities are based on applicable U.S. Department of Health and Human Services (HHS) negotiated rates or sponsor-specified rates. For Mercy Health entities that do not have a negotiated indirect cost rate with HHS, the 10% de minimis indirect cost rate allowed by the Uniform Guidance is used, as applicable. Mercy Health received $30,117,450 of donated pharmaceuticals from the federal stockpile for the year ended June 30, 2022, which is valued based on the fair value of the pharmaceuticals at the time of donation.
Title: 4. COVID-19 PRF and ARP Rural Distribution (AL No. 93.498) Accounting Policies: The accompanying schedule of expenditures of federal awards (Schedule) includes the federal grant activity of Mercy Health and is presented on the accrual basis of accounting. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. Mercy Healths reporting entity is defined in Mercy Healths consolidated financial statements. De Minimis Rate Used: Both Rate Explanation: Indirect cost rates for certain Mercy Health entities are based on applicable U.S. Department of Health and Human Services (HHS) negotiated rates or sponsor-specified rates. For Mercy Health entities that do not have a negotiated indirect cost rate with HHS, the 10% de minimis indirect cost rate allowed by the Uniform Guidance is used, as applicable. The Schedule includes $81,685,379 received from HHS between July 1, 2020 and June 30, 2021, under the Provider Relief Fund (PRF) program under Assistance Listing No. 93.498. In accordance with guidance from HHS, these amounts were presented as Periods 2 and 3 in the HHS PRF Reporting Portal. Such amounts were recognized as other operating revenue in the Mercy Health consolidated financial statements as shown in the Schedule in the years ended June 30, 2022 and 2021. Due to the PRF Reporting requirements, these amounts are not the total PRF received and/or recognized as other operating revenue in the years presented in the Schedule. The amount presented on the Schedule for Assistance Listing No. 93.498 is for the fiscal year ended June 30, 2022. The amount reconciles to the PRF information reported to the Health Resources and Services Administration (HRSA) as follows: See Notes to Schedule of Expenditures of Federal Awards for chart/table.

Finding Details

Finding 2022-001 Activities Allowed or Unallowed and Eligibility Information on the federal program: Federal Grantor: United States Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) Assistance Listing No.: 93.461, COVID-19 HRSA COVID-19 Claims Reimbursement for the Uninsured Program and the COVID-19 Coverage Assistance Fund (HRSA COVID-19 Uninsured Program) Award Period of Performance: 07/01/2021?06/30/2022 Criteria or Specific Requirement (Including Statutory, Regulatory, or Other Citation): Section 200.303 of the Uniform Guidance states the following regarding internal control: ?The non-Federal entity must: (a) Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in ?Standards for Internal Control in the Federal Government? issued by the Comptroller General of the United States or the ?Internal Control Integrated Framework,? issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).? Condition: Mercy Health did not retain supporting documentation over the HRSA COVID-19 Uninsured Program report query logic (the Report) that was developed to identify patients that meet the allowability and eligibility requirements of the HRSA COVID-19 Uninsured Program. In addition, supporting documentation was not retained to validate who had access to modify and run the script, what changes were made to the script, and how any changes to the script were tested and implemented during the fiscal year based on changes to Health Resources and Services Administration (HRSA) guidance. Further, management did not maintain supporting documentation to demonstrate how it validated the completeness and accuracy of the data extracted by the script. In addition, Mercy Health did not retain supporting documentation over its approval of HRSA COVID-19 Uninsured Program claims, determination of a patient?s uninsured/self-pay status, and review of credit balances. While management had a process to identify and review claims for allowability under the HRSA COVID-19 Uninsured Program, determine a patient?s uninsured/self-pay status through third-party insurance discovery, and review of credit balances, sufficient supporting documentation was not retained to support internal controls over the process. Cause: Development of the Report occurred outside of the Information Technology (IT) department that would require a formal process for the development of IT reports, access and program changes; the report resided in the Revenue Cycle department. The Revenue Cycle department did not develop internal control over report writing, program changes and user access. In addition, while management represented that the Report?s logic and subsequent changes to the Report?s logic were reviewed, no audit evidence was retained to support internal controls over that process. Management represented it performed a review of claims charged to the HRSA COVID-19 Uninsured Program for allowability; however, supporting documentation to evidence that the internal controls were sufficiently designed and operating effectively was not maintained. Standard policies, procedures, and internal controls over the review for patient insurance coverage and review of credit balances used in the federal program were not suitability designed to address the unique aspects of the HRSA COVID-19 Uninsured Program. Effect or potential effect: The Report used to identify eligible federal program participants could be inaccurate or incomplete. Unallowable services may be submitted for reimbursement to the HRSA COVID-19 Uninsured Program. A patient may not be uninsured and, therefore, the related encounter may be ineligible for reimbursement under the HRSA COVID-19 Uninsured Program. Credit balances may not be resolved timely and refunds to the HRSA COVID-19 Uninsured Program may not be identified or completed in a timely manner. Questioned costs: None. Context: Total federal expenditures for Assistance Listing 93.461 totaled $14,281,788 for the year ended June 30, 2022. Identification as a repeat finding, if applicable: The finding is a repeat of finding 2021-001 from the prior year. Recommendation: The HRSA COVID-19 Uninsured Program ended in the first quarter of 2022. Therefore, no further changes are required to the current internal controls over this program or the related documentation of the operation of internal controls. If the program were to be reinstated, Mercy Health should implement sufficiently precise internal controls to review changes to the HRSA COVID-19 Uninsured Program to ensure it is administering the program in compliance with the HRSA COVID-19 Uninsured Program regulations. In addition, internal controls should be implemented to ensure claims submitted to the HRSA COVID-19 Uninsured Program meet the allowability criteria established by the HRSA COVID-19 Uninsured Program regulations before claims are submitted to HRSA for reimbursement. Management should retain documentation of the operation of controls responsive to risks related to the data stored in its IT systems as evidence of control activities. Credit balances should be resolved on a timely basis to ensure the HRSA COVID-19 Uninsured Program is refunded timely if third-party insurance is subsequently identified. Views of Responsible Officials: In March 2022, HRSA announced that the HRSA COVID-19 Uninsured Program was ending. Therefore, remediation of internal controls is no longer applicable. If this program is reinstated, Mercy Health will take the necessary steps to ensure proper documentation is retained to provide evidence of our internal control processes.
Finding 2022-002 Reporting Information on the federal program: Federal Grantor: United States Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) Assistance Listing No.: 93.498, COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Provider Relief Fund Reporting Entities: Mercy Hospital Fort Smith, Mercy Hospital Springfield, Mercy Hospital Oklahoma City, Mercy Hospital Joplin Tax Identification Numbers: 710240352, 440552485, 730579285, 270814858 Period of Availability: 01/01/2020?12/31/2021 (Period 2) and 01/01/2020?06/30/2022 (Period 3) Criteria or Specific Requirement (Including Statutory, Regulatory, or Other Citation): Section 200.303 of the Uniform Guidance states the following regarding internal control: ?The non-Federal entity must: (a) Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in ?Standards for Internal Control in the Federal Government? issued by the Comptroller General of the United States or the ?Internal Control Integrated Framework,? issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).? The terms and conditions of the award require the recipient to submit reports as the secretary of HHS determines are needed to ensure compliance with the conditions that are imposed on the payment, and such reports shall be in such form, with such content, as specified by the secretary of HHS in future program instructions directed to all recipients. Condition: The amounts reported for net patient service revenue (NPSR) by payer for calendar year 2021 Quarter 4 (CY2021 Q4) were incorrect. However, total NPSR was correct. Cause: Management?s review of the allocation of total NPSR to the payer classification required in the PRF report was not sufficiently precise to detect that the incorrect quarter?s payer percentages were used to allocate gross revenue for CY2021 Q4. Effect or potential effect: NPSR by payer was incorrectly reported for CY2021 Q4. Questioned costs: None. Context: We tested 5 of 14 Period 2 and 3 PRF Reports submitted to HRSA. For 4 of the 5 Period 2 and 3 PRF reports tested, the NPSR amounts reported by payer were incorrect for CY2021 Q4 as follows (increase/(decrease)): See chart/table in the Schedule of Findings and Questioned Costs. The differences noted by payer resulting from the use of incorrect allocation percentages did not impact total NPSR reported for CY2021 Q4. Total federal expenditures for Assistance Listing 93.498 totaled $81,685,379 for the year ended June 30, 2022. Identification as a repeat finding, if applicable: The finding is not a repeat finding from the prior year. Recommendation: Mercy Health should ensure internal controls over the review of PRF Reports are enhanced to include sufficient precision to allow for accurate reporting of NPSR by payer. Views of Responsible Officials: While there was no impact on total NPSR reported for Q4 2021, we agree that the percentages used to allocate gross revenue by payer were incorrect. Going forward, we will provide additional review of payer allocation percentages to ensure accuracy.
Finding 2022-001 Activities Allowed or Unallowed and Eligibility Information on the federal program: Federal Grantor: United States Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) Assistance Listing No.: 93.461, COVID-19 HRSA COVID-19 Claims Reimbursement for the Uninsured Program and the COVID-19 Coverage Assistance Fund (HRSA COVID-19 Uninsured Program) Award Period of Performance: 07/01/2021?06/30/2022 Criteria or Specific Requirement (Including Statutory, Regulatory, or Other Citation): Section 200.303 of the Uniform Guidance states the following regarding internal control: ?The non-Federal entity must: (a) Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in ?Standards for Internal Control in the Federal Government? issued by the Comptroller General of the United States or the ?Internal Control Integrated Framework,? issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).? Condition: Mercy Health did not retain supporting documentation over the HRSA COVID-19 Uninsured Program report query logic (the Report) that was developed to identify patients that meet the allowability and eligibility requirements of the HRSA COVID-19 Uninsured Program. In addition, supporting documentation was not retained to validate who had access to modify and run the script, what changes were made to the script, and how any changes to the script were tested and implemented during the fiscal year based on changes to Health Resources and Services Administration (HRSA) guidance. Further, management did not maintain supporting documentation to demonstrate how it validated the completeness and accuracy of the data extracted by the script. In addition, Mercy Health did not retain supporting documentation over its approval of HRSA COVID-19 Uninsured Program claims, determination of a patient?s uninsured/self-pay status, and review of credit balances. While management had a process to identify and review claims for allowability under the HRSA COVID-19 Uninsured Program, determine a patient?s uninsured/self-pay status through third-party insurance discovery, and review of credit balances, sufficient supporting documentation was not retained to support internal controls over the process. Cause: Development of the Report occurred outside of the Information Technology (IT) department that would require a formal process for the development of IT reports, access and program changes; the report resided in the Revenue Cycle department. The Revenue Cycle department did not develop internal control over report writing, program changes and user access. In addition, while management represented that the Report?s logic and subsequent changes to the Report?s logic were reviewed, no audit evidence was retained to support internal controls over that process. Management represented it performed a review of claims charged to the HRSA COVID-19 Uninsured Program for allowability; however, supporting documentation to evidence that the internal controls were sufficiently designed and operating effectively was not maintained. Standard policies, procedures, and internal controls over the review for patient insurance coverage and review of credit balances used in the federal program were not suitability designed to address the unique aspects of the HRSA COVID-19 Uninsured Program. Effect or potential effect: The Report used to identify eligible federal program participants could be inaccurate or incomplete. Unallowable services may be submitted for reimbursement to the HRSA COVID-19 Uninsured Program. A patient may not be uninsured and, therefore, the related encounter may be ineligible for reimbursement under the HRSA COVID-19 Uninsured Program. Credit balances may not be resolved timely and refunds to the HRSA COVID-19 Uninsured Program may not be identified or completed in a timely manner. Questioned costs: None. Context: Total federal expenditures for Assistance Listing 93.461 totaled $14,281,788 for the year ended June 30, 2022. Identification as a repeat finding, if applicable: The finding is a repeat of finding 2021-001 from the prior year. Recommendation: The HRSA COVID-19 Uninsured Program ended in the first quarter of 2022. Therefore, no further changes are required to the current internal controls over this program or the related documentation of the operation of internal controls. If the program were to be reinstated, Mercy Health should implement sufficiently precise internal controls to review changes to the HRSA COVID-19 Uninsured Program to ensure it is administering the program in compliance with the HRSA COVID-19 Uninsured Program regulations. In addition, internal controls should be implemented to ensure claims submitted to the HRSA COVID-19 Uninsured Program meet the allowability criteria established by the HRSA COVID-19 Uninsured Program regulations before claims are submitted to HRSA for reimbursement. Management should retain documentation of the operation of controls responsive to risks related to the data stored in its IT systems as evidence of control activities. Credit balances should be resolved on a timely basis to ensure the HRSA COVID-19 Uninsured Program is refunded timely if third-party insurance is subsequently identified. Views of Responsible Officials: In March 2022, HRSA announced that the HRSA COVID-19 Uninsured Program was ending. Therefore, remediation of internal controls is no longer applicable. If this program is reinstated, Mercy Health will take the necessary steps to ensure proper documentation is retained to provide evidence of our internal control processes.
Finding 2022-002 Reporting Information on the federal program: Federal Grantor: United States Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) Assistance Listing No.: 93.498, COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Provider Relief Fund Reporting Entities: Mercy Hospital Fort Smith, Mercy Hospital Springfield, Mercy Hospital Oklahoma City, Mercy Hospital Joplin Tax Identification Numbers: 710240352, 440552485, 730579285, 270814858 Period of Availability: 01/01/2020?12/31/2021 (Period 2) and 01/01/2020?06/30/2022 (Period 3) Criteria or Specific Requirement (Including Statutory, Regulatory, or Other Citation): Section 200.303 of the Uniform Guidance states the following regarding internal control: ?The non-Federal entity must: (a) Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in ?Standards for Internal Control in the Federal Government? issued by the Comptroller General of the United States or the ?Internal Control Integrated Framework,? issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).? The terms and conditions of the award require the recipient to submit reports as the secretary of HHS determines are needed to ensure compliance with the conditions that are imposed on the payment, and such reports shall be in such form, with such content, as specified by the secretary of HHS in future program instructions directed to all recipients. Condition: The amounts reported for net patient service revenue (NPSR) by payer for calendar year 2021 Quarter 4 (CY2021 Q4) were incorrect. However, total NPSR was correct. Cause: Management?s review of the allocation of total NPSR to the payer classification required in the PRF report was not sufficiently precise to detect that the incorrect quarter?s payer percentages were used to allocate gross revenue for CY2021 Q4. Effect or potential effect: NPSR by payer was incorrectly reported for CY2021 Q4. Questioned costs: None. Context: We tested 5 of 14 Period 2 and 3 PRF Reports submitted to HRSA. For 4 of the 5 Period 2 and 3 PRF reports tested, the NPSR amounts reported by payer were incorrect for CY2021 Q4 as follows (increase/(decrease)): See chart/table in the Schedule of Findings and Questioned Costs. The differences noted by payer resulting from the use of incorrect allocation percentages did not impact total NPSR reported for CY2021 Q4. Total federal expenditures for Assistance Listing 93.498 totaled $81,685,379 for the year ended June 30, 2022. Identification as a repeat finding, if applicable: The finding is not a repeat finding from the prior year. Recommendation: Mercy Health should ensure internal controls over the review of PRF Reports are enhanced to include sufficient precision to allow for accurate reporting of NPSR by payer. Views of Responsible Officials: While there was no impact on total NPSR reported for Q4 2021, we agree that the percentages used to allocate gross revenue by payer were incorrect. Going forward, we will provide additional review of payer allocation percentages to ensure accuracy.